首页 | 本学科首页   官方微博 | 高级检索  
     


Neutrophil-mediated proteolysis
Authors:Paul Kubes  Robert Smith  Matthew D. Grisham  D. Neil Granger
Affiliation:(1) Department of Medical Physiology, University of Calgary Calgary, T2N 4N1 Alberta, Canada;(2) Department of Biochemistry, Louisiana State University, Shreveport, Louisiana;(3) Department of Medical Physiology and Biophysics Louisiana Medical Center, Louisiana State University, Shreveport, Louisiana
Abstract:In this study, we assessed the underlying mechanisms by which proteinases released from activated neutrophils mediate fibronectin degradation. Purified human neutrophils (1 X 106) were incubated for 1 hr with 1 mgrM PMA in the absence or presence of different prateinase inhibitors in 96-well microtiter plates that were coated with125I-labeled fibronectin (FN). PMA-activated neutrophils caused 85% of FN to be degraded (versus5% under control conditions). A selective inhibitor of elastase (L658,758), a monoclonal antibody directed against human neutrophilic elastase, and plasma all reduced the: neutrophil-mediated FN degradation by 60%. A monoclonal antibody directed against the neutrophil adhesion glycoprotein CD 11 /CD 18 increased the antiproteoly tic effect of plasma to 70 % but had no effect on the other anti-elastase agents, suggesting that the subjacent space formed by adherent neutrophils restricted to a small degree plasma derived antiproteinases. Agents that blocked cathepsin G or cathepsin G and elastase completely prevented the proteolysis associated with PMA-stimulated neutrophils, suggesting that the actions of elastase may be dependent on the presence of biologically active cathepsin G.Supported by grants from the National Institutes of Health (HL26441) and DK43785 and the Medical Research Council of Canada (MRC). Dr. Paul Kubes is an MRC Scholar.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号